UPDATE 1-Jazz Pharma in $7.2 bln deal for GW Pharma to add cannabis-based epilepsy drug

Retrieved on: 2021-02-03 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

UPDATE 1-Jazz Pharma in $7.2 bln deal for GW Pharma to add cannabis-based epilepsy drug. View article details on hiswai:

Excerpt

... plc in a $7.2 billion cash-and-stock deal to expand its neuroscience business by adding cannabis-based epilepsy treatment to its suite of drugs.

Article found on: www.reuters.com